Sarepta Therapeutics, Inc.
SRPT institutional ownership changes in Q2 2026: 80 institutions opened or added positions, 96 trimmed or exited. SRPT (Sarepta Therapeutics, Inc.) is held by 166 institutional investors as of Q2 2026. Top institutional shareholders: BlackRock, Inc. ($341.3M), State Street Corp. ($160.2M), Vanguard Portfolio Management LLC ($150.5M). Institutions were selling, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Sep 8, 2026 · Activists Aug 13, 2026 · Congress May 6, 2025
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Increased | 19M(+28.7%) | $341.3M | 0.0% | -75.91% | 39 | |
Increased | 8.9M(+34.8%) | $160.2M | 0.0% | -72.76% | 39 | |
Increased | 8.4M(+26.1%) | $150.5M | 0.0% | -15.04% | 37 | |
Increased | 4.6M(+0.1%) | $82.6M | 0.1% | -32.10% | 30 | |
Increased | 4.6M(+0.3%) | $82.5M | 0.0% | -18.06% | 30 | |
Increased | 4.4M(+5.6%) | $78.5M | 0.0% | -39.05% | 31 | |
Decreased | 4.3M(-32.8%) | $76.9M | 0.0% | -15.64% | 0 | |
Increased | 2.8M(+39.4%) | $49.8M | 0.0% | -76.33% | 39 | |
Decreased | 2.6M(-13.5%) | $45.5M | 0.4% | -60.49% | 0 | |
Increased | 2.2M(+204.3%) | $39.6M | 0.0% | -6.67% | 47 | |
Decreased | 2.2M(-15.2%) | $39.6M | 0.0% | -74.97% | 0 | |
Decreased | 2.2M(-5.3%) | $39.4M | 0.1% | -58.42% | 0 | |
Decreased | 2.1M(-4.2%) | $36.9M | 0.0% | -61.43% | 0 | |
Increased | 2M(+89.4%) | $36.7M | 0.0% | -25.65% | 46 | |
Decreased | 1.6M(-27.2%) | $29.2M | 0.0% | -58.09% | 0 | |
Decreased | 1.6M(-11.0%) | $28.6M | 0.0% | -45.67% | 0 | |
Increased | 1.2M(+67.2%) | $21.8M | 0.0% | -76.33% | 42 | |
Decreased | 1.2M(-2.3%) | $21.4M | 0.0% | -21.82% | 0 | |
Increased | 1.2M(+0.6%) | $20.8M | 0.0% | -38.89% | 29 | |
Decreased | 1.1M(-32.6%) | $20.2M | 0.0% | -9.40% | 0 |
Showing 1-20 of 189
| Insider | Trade | Traded |
|---|---|---|
| Wong Ryan Ho-Yan | Tax 13K sh | |
| Rodino-Klapac Louise | Tax 21K sh | |
| Rothfuss Cristin | Tax 22K sh | |
| Estepan Ian Michael | Tax 25K sh | |
| SEVERINO MICHAEL | Vest 756K sh | |
| Nicaise Claude | Vest 17K sh | |
| Chambers Michael Andrew | Vest 17K sh | |
| Wigzell Hans Lennart Rudolf | Vest 17K sh | |
| Barry Richard | Vest 17K sh | |
| BEHRENS M KATHLEEN | Vest 17K sh |
| Member | Trade | Traded |
|---|---|---|
| Gilbert Cisneros | Sale $1,001 - $15,000 |
| Filer | Stake | Filed |
|---|---|---|
| AQR Capital Management, LLC | 5.0% | |
| STATE STREET CORPORATION | 8.4% | |
| Vanguard Portfolio Management | 8.1% | |
| BlackRock, Inc. | 15.8% | |
| Vanguard Capital Management | 5.1% | |
| Vanguard Portfolio Management | 6.4% | |
| The Vanguard Group | 0.0% | |
| AQR Capital Management, LLC | 7.7% | |
| BlackRock, Inc. | 12.6% | |
| D. E. Shaw & Co., L.P. | 1.9% |
SRPTSarepta Therapeutics, Inc.Continue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about SRPT
Who owns SRPT?
166 institutional investors held SRPT on June 30, 2026, led by BlackRock, Inc. ($341.3M), State Street Corp. ($160.2M) and Vanguard Portfolio Management LLC ($150.5M).
How many hedge funds hold SRPT?
166 institutional investors reported SRPT in their 13F filings for the quarter ended June 30, 2026, $1.8B in all. 5 of them are rated Elite.
Are institutions buying or selling SRPT?
Selling, on balance. In Q2 2026, 96 institutions trimmed or exited SRPT and 80 institutions opened or added to positions.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer